Chemical biology of compounds obtained from screening using disease models.

about

Chemical genetics-based development of small molecules targeting hepatitis C virus.Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathways.

P2860

Q40063790-B5258ECC-1F00-4236-BC27-9870F8F4DEF7 Q54917620-6A7867F0-218D-4EFD-BA63-2F5886C8DA43

P2860

Chemical biology of compounds obtained from screening using disease models.

Item

http://www.wikidata.org/entity/Q38547710

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Chemical biology of compounds obtained from screening using disease models.

@en

type

Item

label

Chemical biology of compounds obtained from screening using disease models.

@en

prefLabel

Chemical biology of compounds obtained from screening using disease models.

@en

P1476

Chemical biology of compounds obtained from screening using disease models.

@en

P2093

Estu Tashiro

http://www.w3.org/2001/XMLSchema#string

Masaya Imoto

http://www.w3.org/2001/XMLSchema#string

P2860

Transgenic mouse proteomics identifies new 14-3-3-associated proteins involved in cytoskeletal rearrangements and cell signaling

E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton

The Bcl-2 apoptotic switch in cancer development and therapy

Virtual Computational Chemistry Laboratory – Design and Description

Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma

Cell migration: a physically integrated molecular process

Mutations of the BRAF gene in human cancer

A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics

P2888

s12272-015-0633-4

P304

1651-1660

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12272-015-0633-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280121558

http://www.w3.org/2001/XMLSchema#string

P6179

1013101059

http://www.w3.org/2001/XMLSchema#string

P698

26177809

http://www.w3.org/2001/XMLSchema#string

Chemical biology of compounds obtained from screening using disease models.

about

P2860

P2860

Chemical biology of compounds obtained from screening using disease models.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698